A Boston biotech company working on a new kind of weight-loss pill to reduce obesity has received a $12 million boost from investors that it will use to continue clinical trials and development.
"It will help you to lose weight ... by making you feel satisfied with smaller portions," said Yishai Zohar CEO and founder of Gelesis. "It's a capsule that contains thousands of small particles that can absorb 100 times its original weight in gastric fluid."
Regulated as a medical device rather than medication, Gelesis100 is a "smart pill" whose particles travel through the stomach and the small and large intestines, making the patient feel full from less food and for longer.
"We don't want to prevent people from eating, we just want them to eat a little bit less," Zohar said.
The infusion of cash comes from the Pritzker/Vlock Family Office, founder PureTech and undisclosed investors, the company said.
Dr. Caroline Apovian, a professor at the Boston University School of Medicine who serves on many advisory boards for obesity treatments — including Gelesis — said the current treatment options aren't sufficient.
"We need more options," she said. "There are people who need to be treated who may not be able to tolerate medication."
The other alternative is surgery, but many people don't want to undergo such an invasive procedure. And an increasing number of adults are being diagnosed as obese, Apovian said.
"This is an alarming rate of increase," Apovian said. "We're at epidemic levels."
Zohar said development is continuing, but the pill is still several years from being commercially available.
Anda sedang membaca artikel tentang
Hub co. raises $12M for diet pill
Dengan url
http://bintanggugel.blogspot.com/2014/05/hub-co-raises-12m-for-diet-pill.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Hub co. raises $12M for diet pill
namun jangan lupa untuk meletakkan link
Hub co. raises $12M for diet pill
sebagai sumbernya
0 komentar:
Posting Komentar